Johnson & Johnson (ETR:JNJ)
134.12
-0.28 (-0.21%)
Jun 5, 2025, 2:38 PM CET
Johnson & Johnson Revenue
Johnson & Johnson had revenue of $21.89B USD in the quarter ending March 30, 2025, with 2.39% growth. This brings the company's revenue in the last twelve months to $89.33B, up 4.30% year-over-year. In the year 2024, Johnson & Johnson had annual revenue of $88.82B with 4.30% growth.
Revenue (ttm)
$89.33B
Revenue Growth
+4.30%
P/S Ratio
3.91
Revenue / Employee
$646.86K
Employees
138,100
Market Cap
322.69B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 29, 2024 | 88.82B | 3.66B | 4.30% |
Dec 31, 2023 | 85.16B | 5.17B | 6.46% |
Jan 1, 2023 | 79.99B | 1.25B | 1.59% |
Jan 2, 2022 | 78.74B | -3.84B | -4.65% |
Jan 3, 2021 | 82.58B | 525.00M | 0.64% |
Dec 29, 2019 | Pro | Pro | Pro |
Dec 30, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Jan 1, 2017 | Pro | Pro | Pro |
Jan 3, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.14B |
Merck KGaA | 21.32B |
Bayer Aktiengesellschaft | 46.58B |
Fresenius SE & Co. KGaA | 22.13B |
Fresenius Medical Care AG | 19.49B |
Sartorius Aktiengesellschaft | 3.44B |
Carl Zeiss Meditec AG | 2.17B |
Fielmann Group AG | 2.33B |
Johnson & Johnson News
- 5 days ago - Tech stocks struggle while healthcare gains: Today's market overview - Forexlive
- 5 days ago - Johnson & Johnson: Relative Stability In A Wild 2025 Stock Market - Seeking Alpha
- 6 days ago - J&J CEO Joaquin Duato on cancer treatments, M&A outlook and 'most favored nation' policy - CNBC
- 6 days ago - Watch CNBC's full interview with Johnson & Johnson chairman and CEO Joaquin Duato - CNBC
- 7 days ago - Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results - Wallstreet:Online
- 7 days ago - Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results - Business Wire
- 7 days ago - Johnson & Johnson (JNJ) Presents at the Bernstein's 41st Annual Strategic Decisions Conference (Transcript) - Seeking Alpha
- 7 days ago - P/E Ratio Insights for Johnson & Johnson - Benzinga